JPRN-UMIN000019029招募中未知
The utility of 11C-choline PET/CT in prostate patients of PSA failure - 11C-choline PET/CT in PSA failure
Radiology, Hyogo College of Medicine0 个研究点目标入组 20 人开始时间: 2015年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT. The sensitivity/specificity/accuracy/AUC for choline-PET for diagnosing local lesions were 90.9%/100%/95.0%/1.0, whereas those for FDG-PET were 45.5%/100%/75.0%/0.773. Those for choline-PET for node metastasis were 88.9%/100%/95.0%/0.944, and those for FDG-PET were 44.4%/100%/75.0%/0.722. Those for choline-PET for bone metastasis were 84.6%/100%/90.0%/0.951, and those for FDG-PET were 76.9%/100%/85.0%/0.962.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 100years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •*The patients who cannot keep face up position because of sharp pain in succession for around 30 minutes. *The patients with the extreme claustrophobia. *The patients whom the ADL which I become independent and can inspect is not kept. *The patients who a study person in charge is judged to be inappropriate.
研究者
相似试验
已完成
早期 1 期
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate CancerProstate CancerNCT03768349Mayo Clinic250
Approved For Marketing
不适用
Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access StudyCancer of the ProstateNCT02355054Washington University School of Medicine
No Longer Available
不适用
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission TomographyRecurrent Prostate CancerProstate CancerNCT02531672Memorial Sloan Kettering Cancer Center
已完成
2 期
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate CarcinomaProstate CancerNCT01304485Phoenix Molecular Imaging2,000
Unknown
不适用
Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate CancerProstate CancerNCT01769950Bangalore Institute of Oncology120